TLX
Telix Pharmaceuticals Ltd. ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.85
-0.04 ▼ -0.51%
🌙 3월 13일 5:13 PM ET (한국 3/14 06:13)
$7.80
-0.05 ▼ -0.64%
| Index | - | P/E | - | EPS (ttm) | -0.02 | Insider Own | - | Shs Outstand | 0.33B | Perf Week | 4.39% |
| Market Cap | 2.66B | Forward P/E | 71.2 | EPS next Y | 218.8% | Insider Trans | - | Shs Float | - | Perf Month | 13.28% |
| Enterprise Value | 2.99B | PEG | - | EPS next Q | - | Inst Own | 0.33% | Short Float | - | Perf Quarter | -20.87% |
| Income | -0.01B | P/S | 3.31 | EPS this Y | 263.91% | Inst Trans | 0.93% | Short Ratio | 1.53 | Perf Half Y | -15.77% |
| Sales | 0.80B | P/B | 6.4 | EPS next 5Y | - | ROA | -0.67% | Short Interest | 0.37M | Perf YTD | 4.81% |
| Book/sh | 1.23 | P/C | 18.75 | EPS past 3/5Y | 55.05% 29.38% | ROE | -1.86% | 52W High | -60.75% ($20.00) | Perf Year | -53.8% |
| Cash/sh | 0.42 | P/FCF | - | Sales past 3/5Y | 93.54% 195.21% | ROIC | -0.83% | 52W Low | 25% ($6.28) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 76.17 | EPS Y/Y TTM | -121.18% | Gross Margin | 53.15% | Volatility(W/M) | 3.65% 3.72% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 3.71 | Sales Y/Y TTM | 55.73% | Oper. Margin | 2.2% | ATR (14) | 0.39 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.27 | EPS Q/Q | - | Profit Margin | -0.89% | RSI (14) | 57.61 | Recom | 1.13 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.43 | Sales Q/Q | - | SMA20 | 9.62% ($7.16) | Beta | 0.14 | Target Price | $16.69 |
| Payout | - | Debt/Eq | 1.12 | Earnings | 2000000 | SMA50 | 7.03% ($7.33) | Rel Volume | 0.49 | Prev Close | $7.89 |
| Employees | - | LT Debt/Eq | 1.08 | EPS/Sales Surpr. | -158.23% -1.22% | SMA200 | -26.79% ($10.72) | Avg Volume(3M) | 0.24M | Price | $7.85 |
| IPO | 2024/11/14 | Option/Short | No/Yes | Trades | 860 | Volume | 120,051 | Change | -0.51% |
뉴스 로딩 중...